Search Results - "Rexroad, Vivian"
-
1
Stability of Nevirapine Suspension in Prefilled Oral Syringes Used for Reduction of Mother-to-Child HIV Transmission
Published in Journal of acquired immune deficiency syndromes (1999) (01-11-2006)“…OBJECTIVE:To reduce mother-to-child transmission (MTCT) of HIV, we assessed the stability of nevirapine suspension in an oral dosing syringe over a range of…”
Get full text
Journal Article -
2
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children
Published in The Journal of infectious diseases (11-06-2020)“…Abstract Background Respiratory syncytial virus (RSV) is the leading viral cause of severe pediatric respiratory illness, and vaccines are needed. Live RSV…”
Get full text
Journal Article -
3
Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children
Published in The Journal of infectious diseases (13-12-2022)“…This United States-based study compared 2 candidate vaccines: RSV/ΔNS2/Δ1313/I1314L, attenuated by NS2 gene-deletion and temperature-sensitivity mutation in…”
Get full text
Journal Article -
4
Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children
Published in The Journal of infectious diseases (03-02-2020)“…Abstract Background The safety and immunogenicity of live respiratory syncytial virus (RSV) candidate vaccine, LID/ΔM2-2/1030s, with deletion of RSV…”
Get full text
Journal Article -
5
Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children
Published in The Journal of infectious diseases (11-04-2018)“…Abstract Background Live respiratory syncytial virus (RSV) candidate vaccine LIDΔM2-2 is attenuated by deletion of the RSV RNA regulatory protein M2-2,…”
Get full text
Journal Article -
6
Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children
Published in The Journal of infectious diseases (11-04-2018)“…Abstract Background Respiratory syncytial virus (RSV) is the most important viral cause of severe respiratory illness in young children and lacks a vaccine…”
Get full text
Journal Article -
7
Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials
Published in The Lancet (British edition) (26-07-2008)“…Summary Background UNICEF/WHO recommends that infants born to HIV-infected mothers who do not have access to acceptable, feasible, affordable, sustainable, and…”
Get full text
Journal Article -
8
Bioavailability of Once- and Twice-Daily Regimens of Didanosine in Human Immunodeficiency Virus-Infected Children
Published in Antimicrobial Agents and Chemotherapy (01-05-2000)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
9
Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial
Published in BMC pregnancy and childbirth (17-01-2023)“…This exploratory analysis investigates the prevalence and risk factors of neurocognitive toxicity in postpartum women on HIV treatment in response to a concern…”
Get full text
Journal Article -
10
Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Overattenuated
Published in Open forum infectious diseases (01-06-2019)“…Abstract Background The live respiratory syncytial virus (RSV) candidate vaccine LIDcpΔM2-2 is attenuated through deletion of M2-2 and 5 cold-passage…”
Get full text
Journal Article -
11
Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial
Published in EClinicalMedicine (01-04-2023)“…Isoniazid preventive therapy (IPT) initiation during pregnancy was associated with increased incidence of adverse pregnancy outcomes in the TB APPRISE trial…”
Get full text
Journal Article -
12
Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trialResearch in context
Published in EClinicalMedicine (01-04-2023)“…Background: Isoniazid preventive therapy (IPT) initiation during pregnancy was associated with increased incidence of adverse pregnancy outcomes in the TB…”
Get full text
Journal Article -
13
-
14
-
15
High Infectivity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID ΔM2-2) in Infants and Children
Published in Open forum infectious diseases (09-12-2015)Get full text
Journal Article -
16
1924High Infectivity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID ΔM2-2) in Infants and Children
Published in Open forum infectious diseases (01-12-2015)Get full text
Journal Article -
17
Current Management of Infectious Complications in the Injecting Drug User
Published in Journal of substance abuse treatment (01-03-1998)“…The diagnosis and management of infectious complications associated with injection drug use (IDU) are among some of the more challenging aspects of working…”
Get full text
Journal Article